Search Results

There are 8361 results for: content related to: Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials *

  1. You have free access to this content
    Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness

    Clinical & Experimental Immunology

    Volume 134, Issue 1, October 2003, Pages: 98–106, G. A. D. HARDY, N. IMAMI, A. K. SULLIVAN, A. PIRES, C. T. BURTON, M. R. NELSON, B. G. GAZZARD and F. M. GOTCH

    Version of Record online : 3 SEP 2003, DOI: 10.1046/j.1365-2249.2003.02256.x

  2. You have full text access to this OnlineOpen article
    Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

    HIV Medicine

    A Bamford, A Turkova, H Lyall, C Foster, N Klein, D Bastiaans, D Burger, S Bernadi, K Butler, E Chiappini, P Clayden, M Della Negra, V Giacomet, C Giaquinto, D Gibb, L Galli, M Hainaut, M Koros, L Marques, E Nastouli, T Niehues, A Noguera-Julian, P Rojo, C Rudin, HJ Scherpbier, G Tudor-Williams, SB Welch and (PENTA Steering Committee)

    Version of Record online : 3 FEB 2015, DOI: 10.1111/hiv.12217

  3. Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia

    Journal of Medical Virology

    Volume 85, Issue 8, August 2013, Pages: 1394–1401, Azzania Fibriani, Rudi Wisaksana, Agnes Indrati, Yovita Hartantri, David van de Vijver, Martin Schutten, Bachti Alisjahbana, Primal Sudjana, Charles A.B. Boucher, Reinout van Crevel and Andre van der Ven

    Version of Record online : 30 MAY 2013, DOI: 10.1002/jmv.23606

  4. You have free access to this content
    Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy

    Tropical Medicine & International Health

    Volume 19, Issue 5, May 2014, Pages: 501–513, Rubeena Ramjan, Alexandra Calmy, Marco Vitoria, Edward J. Mills, Andrew Hill, Graham Cooke and Nathan Ford

    Version of Record online : 17 MAR 2014, DOI: 10.1111/tmi.12297

  5. HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa

    HIV Medicine

    Volume 18, Issue 2, February 2017, Pages: 104–114, TM Rossouw, M Nieuwoudt, J Manasa, G Malherbe, RJ Lessells, S Pillay, S Danaviah, P Mahasha, G van Dyk and T de Oliveira

    Version of Record online : 28 JUN 2016, DOI: 10.1111/hiv.12400

  6. Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens

    HIV Medicine

    Volume 17, Issue S5, October 2016, Pages: 3–16, F Raffi, S Esser, G Nunnari, I Pérez-Valero and L Waters

    Version of Record online : 7 OCT 2016, DOI: 10.1111/hiv.12440

  7. You have free access to this content
    Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, β  -chemokines and IL-16 secretion in HIV-1 infection

    Clinical & Experimental Immunology

    Volume 130, Issue 2, November 2002, Pages: 286–292, C. T. BURTON, G. A. D. HARDY, A. K. SULLIVAN, M. R. NELSON, B. GAZZARD, F. M. GOTCH and N. IMAMI

    Version of Record online : 17 OCT 2002, DOI: 10.1046/j.1365-2249.2002.01993.x

  8. You have free access to this content
    Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002

    HIV Medicine

    Volume 7, Issue 1, January 2006, Pages: 64–66, A Fischer, J-C Karasi, D Kibibi, C Omes, C Lambert, A Uwayitu, R Hemmer, J Van Den Ende, J-C Schmit and V Arendt

    Version of Record online : 24 NOV 2005, DOI: 10.1111/j.1468-1293.2005.00338.x

  9. You have free access to this content
    Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study

    HIV Medicine

    Volume 14, Issue 7, August 2013, Pages: 401–409, JB Dumond, JL Adams, HMA Prince, RL Kendrick, R Wang, SH Jennings, S Malone, N White, C Sykes, AH Corbett, KB Patterson, A Forrest and ADM Kashuba

    Version of Record online : 24 FEB 2013, DOI: 10.1111/hiv.12017

  10. You have full text access to this OnlineOpen article
    Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study

    Pharmacology Research & Perspectives

    Volume 5, Issue 2, April 2017, Ronald Kiguba, Charles Karamagi and Sheila M. Bird

    Version of Record online : 17 FEB 2017, DOI: 10.1002/prp2.298

  11. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 9, September 2016, Pages: 1052–1060, Marita Mann, Assegid Mengistu, Johannes Gaeseb, Evans Sagwa, Greatjoy Mazibuko, Jared M. Baeten, Joseph B. Babigumira, Louis P. Garrison and Andy Stergachis

    Version of Record online : 2 MAY 2016, DOI: 10.1002/pds.4022

  12. Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients

    HIV Medicine

    Volume 16, Issue 7, August 2015, Pages: 403–411, A Abdissa, MF Olsen, D Yilma, M Tesfaye, T Girma, M Christiansen, CM Hagen, L Wiesner, S Castel, A Aseffa, H McIlleron, C Pedersen, H Friis and AB Andersen

    Version of Record online : 13 MAY 2015, DOI: 10.1111/hiv.12225

  13. Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 3, March 2015, Pages: 298–306, A Olagunju, O Bolaji, A Amara, L Else, O Okafor, E Adejuyigbe, J Oyigboja, D Back, S Khoo and A Owen

    Version of Record online : 20 JAN 2015, DOI: 10.1002/cpt.43

  14. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy

    HIV Medicine

    Volume 16, Issue 9, October 2015, Pages: 553–562, S Hattab, M Guiguet, G Carcelain, S Fourati, A Guihot, B Autran, F Caby, A-G Marcelin, D Costagliola and C Katlama

    Version of Record online : 6 MAY 2015, DOI: 10.1111/hiv.12257

  15. You have free access to this content
    Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?

    Tropical Medicine & International Health

    Volume 20, Issue 7, July 2015, Pages: 914–918, Niklaus D. Labhardt, Joëlle Bader, Thabo Ismael Lejone, Isaac Ringera, Daniel Puga, Tracy R. Glass and Thomas Klimkait

    Version of Record online : 2 APR 2015, DOI: 10.1111/tmi.12509

  16. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons

    HIV Medicine

    Volume 17, Issue 2, February 2016, Pages: 83–88, L Ryom, C Boesecke, V Gisler, C Manzardo, JK Rockstroh, M Puoti, H Furrer, JM Miro, JM Gatell, A Pozniak, G Behrens, M Battegay, JD Lundgren and on behalf of the EACS Governing Board

    Version of Record online : 8 NOV 2015, DOI: 10.1111/hiv.12322

  17. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis

    Liver International

    Volume 25, Issue 1, February 2005, Pages: 101–108, Klaus Radecke, Nils R. Frühauf, Michael Miller, Birgit Ross, Roland Köditz, Massimo Malagó, Christoph E. Broelsch, Guido Gerken and Ulrich Treichel

    Version of Record online : 7 FEB 2005, DOI: 10.1111/j.1478-3231.2005.01031.x

  18. You have full text access to this OnlineOpen article
    Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

    Intervention Review

    The Cochrane Library

    Lawrence Mbuagbaw, Sara Mursleen, James H Irlam, Alicen B Spaulding, George W Rutherford and Nandi Siegfried

    Published Online : 10 DEC 2016, DOI: 10.1002/14651858.CD004246.pub4

  19. Role of Cytochrome P450 2B6 Pharmacogenomics in Determining Efavirenz-Mediated Central Nervous System Toxicity, Treatment Outcomes, and Dosage Adjustments in Patients with Human Immunodeficiency Virus Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 12, December 2016, Pages: 1245–1254, Teresa T. Vo and Sheeba Varghese Gupta

    Version of Record online : 4 DEC 2016, DOI: 10.1002/phar.1852

  20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

    Intervention Review

    The Cochrane Library

    Amy S Sturt, Emily Kainne Dokubo and Tin Tin Sint

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD008440